By Chrissy Buteas, President and Chief Executive Officer, HealthCare Institute of New Jersey (HINJ) and William Mullen, President, New Jersey Building and Construction Trades Council
October 28, 2025 ― New Jersey faces an unprecedented opportunity over the next few months as America’s pharmaceutical industry looks to double down on American investment by relocating overseas R&D and manufacturing facilities to various locations around the United States and expanding some of our American-based facilities.
These investments in America will mean tens (if not hundreds) of billions of dollars in construction projects, increased jobs and greater economic activity for whatever states are lucky enough – or smart enough – to attract these companies, their new facilities, and the jobs they will generate. Read the full op-ed here.